VERU VERU

Q: What is the current share price of VERU?

As of 2026-08-05 17:25 PDT, VERU trades at $2.33 on NASDAQ/NYSE. Its 52-week range is $2.09 to $4.90.

Q: What is the market capitalisation of VERU?

VERU has a market capitalisation of $34.64M on NASDAQ/NYSE.

Q: What is the P/E ratio of VERU?

VERU trades at a trailing price-to-earnings (P/E) ratio of -1.50. Its price-to-book (P/B) ratio is 1.89.

Q: What is the return on equity (ROE) of VERU?

VERU has a return on equity (ROE) of -123.97%.

Q: Is VERU a good stock to buy?

This page provides a data-driven analysis of VERU, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$2.33

-52.45% 1Y

Mkt Cap$34.64M

P/E-1.50

P/B1.89

52W High$4.90

52W Low$2.09

Book Value$1.23

EPS (TTM)$-1.55

Company Overview

VERU (VERU) is a publicly traded company listed on with a market capitalization of $34.64M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.17.

Growth & Price Performance

Stock Price Performance

1 Year:	-52.45%
6 Months:	-8.98%
3 Months:	+5.43%
1 Month:	-19.10%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 9% of range

$2.09 $4.90

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)44.10 · Neutral

Price Performance

1M-19.10%

3M+5.43%

6M-8.98%

1Y-52.45%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Trading 52.5% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-1.50

Industry PE

Forward P/E

PEG Ratio

Book Value

$1.23

Price to Book

1.89

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

Profit 5Y

Revenue (YoY)

Earnings (YoY)

Profitability & Returns

ROCE

ROE

-123.97%

ROA

-76.17%

Profit Margin

Op Margin

Gross Margin

EPS (Latest Qtr)

$-0.12

EPS (TTM)

$-1.55

Balance Sheet & Liquidity

Debt/Equity

0.17

Quick Ratio

1.90

Current Ratio

2.43

Debt

$3.12M

Total Assets

$43.08M

Current Assets

$33.36M

Working Capital

$11.13M

Ownership

Promoter Holding

9.78%

Chg in Prom Hold

FII / Inst Holding

24.58%

Chg in FII Hold

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

EBITDA

$-35.38M

Free Cash Flow

$-30.04M

Operating Cash Flow

$-30.04M

Shares Outstanding

14.87M

Gross Margin

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Sep 2014	Dec 2014	Mar 2015	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Dec 2018	Mar 2019	Jun 2019	Dec 2019	Mar 2020	Jun 2020	Dec 2020	Mar 2021	Jun 2021	Dec 2021	Mar 2022	Jun 2022	Dec 2022	Mar 2023	Jun 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	2.59M	2.57M	5.50M	6.37M	6.98M	9.73M	10.58M	9.94M	10.32M	14.62M	13.34M	17.66M	14.14M	13.03M	9.60M	2.51M	6.59M	3.34M	2.14M	4.14M	3.95M	-	0	0	0	0	0
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	2.89M	3.82M	6.39M	4.63M	4.12M	5.40M	2.85M	3.23M	1.87M	1.65M	1.28M	2.29M	1.79M	1.31M	1.20M	3.07M	4.64M	4.61M	6.57M	7.27M	7.44M	6.52M	10.84M	10.91M	13.87M	11.84M	11.18M	7.07M	702.05K	4.09M	1.23M	1.15M	678.30K	1.34M	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.10M	8.03M	7.46M	5.42M	7.22M
Operating Income	-	1.45M	2.95M	1.45M	-	2.39M	70.42K	848.52K	-	-1.87M	-2.58M	-1.27M	-	-7.44M	-4.70M	-4.96M	-1.01M	-2.12M	-1.84M	-1.78M	-299.68K	-1.39M	19.19M	-1.47M	-2.87M	-4.96M	-11.76M	-21.82M	-37.45M	-34.41M	-13.74M	-7.39M	-8.89M	-10.55M	-	-9.10M	-8.03M	-7.46M	-5.42M	-7.22M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9.07M	-8.00M	-7.43M	-5.40M	-7.19M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7.85M	-7.32M	1.30M	-5.33M	-3.09M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-566.12K	804.92K	1.67M	1.17M	702.57K	1.49M	35.05K	570.26K	-1.75M	-1.37M	-1.78M	-789.89K	-2.68M	-4.26M	-3.83M	-7.93M	-2.15M	-4.03M	-2.77M	-3.31M	-810.51K	-3.03M	17.23M	-2.85M	-2.69M	-6.38M	-14.18M	-22.20M	-38.71M	-33.79M	-12.52M	-8.28M	-10.03M	-10.97M	-	-7.90M	-7.33M	1.45M	-5.33M	-2.74M
Diluted EPS	-0.02	0.03	0.06	0.04	0.02	0.05	0.00	0.02	-0.06	-0.04	-0.06	-0.03	-0.12	-	-	-	-	-	-	-0.05	-0.01	-0.05	0.23	-0.04	-0.03	-0.08	-0.18	-0.28	-0.48	-0.42	0.07	-0.08	-0.07	-	-0.60	-0.50	-0.50	-	-0.26	-0.12
R&D Expense	-	-	-	-	-	-	35.12K	22.72K	-	171.10K	1.21M	302.07K	-	1.96M	2.08M	3.79M	2.36M	2.91M	4.87M	5.30M	3.93M	4.44M	5.68M	7.57M	11.19M	10.08M	15.54M	18.13M	20.61M	17.86M	8.79M	1.66M	2.99M	4.85M	5.72M	3.93M	3.02M	-	1.34M	3.15M

Profit & Loss (Annual)

Figures in USD.

Metric	Sep 2009	Sep 2010	Sep 2011	Sep 2012	Sep 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Revenue	27.54M	22.22M	18.57K	35.03M	31.46M	24.49M	32.60M	22.13M	13.66M	15.86M	31.80M	42.59M	-	39.35M	16.30M	0	0
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	13.33M	8.76M	8.73M	11.03M	-
Gross Profit	13.52M	12.92M	9.87M	20.62M	17.50M	13.12M	18.97M	13.35M	7.02M	8.77M	21.66M	30.79M	47.93M	30.59M	7.57M	5.85M	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	114.08M	103.17M	37.39M	35.53M
Operating Income	4.72M	4.35M	3.30M	10.94M	9.79M	3.92M	6.62M	3.02M	-8.49M	-20.87M	-6.44M	-14.75M	-	-83.49M	-95.61M	-37.39M	-35.53M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-79.23M	-89.98M	-37.12M	-35.38M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	4.85M	4.37M	2.43M	607.47K	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-83.80M	-92.67M	-35.26M	-15.68M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-3.13M	236.40K	480.21K	725.10K	-
Net Income	6.54M	6.74M	5.40M	15.30M	14.34M	2.43M	4.35M	344.73K	-6.61M	-23.94M	-12.02M	-18.97M	-	-84.04M	-93.15M	-37.80M	-22.73M
Diluted EPS	0.24	0.24	0.19	0.53	0.50	0.08	0.15	0.01	-0.25	-	-	-0.28	-	-10.50	-11.00	-2.80	-1.55
R&D Expense	105.92K	381	10.93K	5.28K	4.75K	5.58K	219.81K	99.39K	3.08M	10.85M	13.74M	16.94M	32.69M	70.65M	51.20M	12.78M	15.59M

Balance Sheet (Annual)

Figures in USD.

Metric	Sep 2008	Sep 2009	Sep 2010	Sep 2011	Sep 2012	Sep 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Assets	-	-	18.37M	19.44M	30.45M	35.17M	31.67M	37.47M	38.62M	55.34M	48.45M	53.63M	51.54M	-	135.36M	50.02M	60.42M	29.84M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	104.00M	22.93M	35.22M	18.92M
Cash & Equivalents	1.92M	2.81M	2.92M	4.25M	5.30M	8.92M	5.80M	4.11M	-	-	-	-	-	-	80.19M	9.63M	24.92M	15.79M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	5.57M	8.62M	6.70M	4.14M	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	8.79M	3.55M	4.51M	3.96M	-
Total Liabilities	-	-	2.24M	2.69M	6.23M	3.77M	3.61M	4.34M	4.69M	6.88M	18.97M	21.30M	21.43M	-	52.56M	30.34M	28.10M	11.50M
Current Liabilities	-	-	1.94M	2.29M	5.86M	3.47M	3.38M	4.23M	3.35M	5.49M	13.55M	14.02M	14.73M	-	38.71M	17.81M	11.87M	7.79M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	1.75M	-	-	9.40M	9.66M	8.87M	8.85M	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.88M	14.41M	13.52M	3.12M
Total Equity	9.71M	12.95M	16.13M	16.75M	24.22M	31.40M	28.07M	33.13M	33.93M	48.45M	29.48M	32.33M	30.11M	-	82.80M	19.68M	32.32M	18.33M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.27M	9.40M	14.86M	14.87M

Cash Flows (Annual)

Figures in USD.

Metric	Sep 2009	Sep 2010	Sep 2011	Sep 2012	Sep 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Operating Cash Flow	5.75M	3.99M	6.97M	10.36M	11.79M	-	-	-	982.89K	-11.55M	-5.49M	-1.93M	-	-47.51M	-88.01M	-21.68M	-30.04M
Investing Cash Flow	-1.50M	49.36K	-46.29K	-654.18K	-302.20K	-	-	-	-90.37K	-50.65K	-108.52K	-105.76K	-	4.27M	6.33M	146.21K	25.14M
Financing Cash Flow	-3.24M	-3.93M	-5.59M	-8.66M	-7.86M	-	-	-	-	12.08M	8.13M	9.33M	-	1.07M	11.11M	36.83M	-4.22M
Capital Expenditure	-1.64M	-51.13K	-46.29K	-718.30K	-302.20K	-97.31K	-135.42K	-6.37K	-133.49K	-50.65K	-108.52K	-105.76K	-	-733.05K	-665.70K	-158.32K	-1.08K
Free Cash Flow	4.10M	3.94M	6.92M	9.64M	11.49M	-	-	-	849.40K	-11.60M	-5.59M	-2.04M	-	-48.24M	-88.68M	-21.84M	-30.04M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-42.17M	-70.57M	15.29M	-9.12M
Share Buybacks	3.83M	349.06K	33.06K	289.61K	395.67K	737.75K	950	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-	6.20M	5.50M	6.20M	7.50M	6.10M	-	-	-	-	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Sep 2009	Sep 2010	Sep 2011	Sep 2012	Sep 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Gross Margin %	49.1%	58.2%	53,138.6%	58.9%	55.6%	53.6%	58.2%	60.3%	51.4%	55.3%	68.1%	72.3%	-	77.7%	46.4%	-	-
Operating Margin %	17.1%	19.6%	17,750.3%	31.2%	31.1%	16.0%	20.3%	13.6%	-62.2%	-131.6%	-20.2%	-34.6%	-	-212.1%	-586.6%	-	-
Net Margin %	23.7%	30.3%	29,081.9%	43.7%	45.6%	9.9%	13.3%	1.6%	-48.4%	-150.9%	-37.8%	-44.5%	-	-213.5%	-571.6%	-	-
ROE %	50.4%	41.8%	32.2%	63.2%	45.7%	8.7%	13.1%	1.0%	-13.6%	-81.2%	-37.2%	-63.0%	-	-101.5%	-473.4%	-117.0%	-124.0%
ROCE %	-	26.5%	19.2%	44.5%	30.9%	13.9%	19.9%	8.6%	-17.0%	-59.8%	-16.2%	-40.1%	-	-86.4%	-296.8%	-77.0%	-161.1%

Shareholding Pattern

Insiders

9.78%

Institutions

24.58%

Public Float

27.24%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for VERU

Google News Mon, 03 Aug 2026

Veru's obesity study expects interim data in 2027 - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaUVIcXpYT2ZycTdmcnFqTmZyd25FaVlzM3MyUThYLXJ0aHJjSG44S3F4T0VpR24zWUY5TlZaZDI0aExnakJBemVjYkxnQ21CWkV1bDUzeDJaQ3l5cy12bVMwaERhenJwVDAzeFl4Q2tvcGE3ZW1jWTJhNW0tMlYtOW9YMFhPc1pLalFLcG…

Google News Mon, 03 Aug 2026

Veru Inc. Announces August 10, 2026 Conference Call to Discuss Fiscal Third Quarter Results and Business Update - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxOVWlHbW1FWnFpRFppaDZhaEdOMnBwaXBVZ1dQLU5JM3U2c1Nab2NtM2FYeGVtcHc3Z1E3NU5RVXNjeVAxRjV5LW53YW1sSlFNdHpQYzhzR21CallsTlV6RENsTWFRSjRIQmJHa014MVpaNmRhQlg5d0QyS2o1cXVGOWdXd3dIRjZ3TWNJS3…

Google News Fri, 05 Jun 2026

Veru And 2 Other Intriguing Penny Stocks To Watch - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNbmh4Nkx1RVlxSEd0dEUwWnF2c1owOHpaU3NpcjhsclJMQnl1ZURlWG1feEZncWJrYzlIQXlfVHA4a3JxODZDX3RTNml6d0V1dE11Zlo2d1VqazB1amQxNGs0bXFsZXdvSnBFMldTaU9JelZJSEdUT0dQaURzcWZnRnp6MWRpQ0pHakhtNV…

Google News hu, 25 Jun 2026

VERU Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9UdDE5YkRsU0FNenFvU3FyMEFDUURkSWpzeGNGTVBpek5id0czeXQxVDVRbjA2NlhNNTI4THhDUmtnZlp0ZkxBRks3enVPSDNGck5QUlAxTVJjcXEwZ2RmOU5FckdBV3Yxc0h0RHRaTjNhTEhnU0N4NjNR?oc=5" target="_blank">VER…

Google News hu, 04 Jun 2026

Veru stock holds at Outperform as Oppenheimer cites Novo deal - Investing.com

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxORDRXaTVVRnY3MW96dXAtUnVrNllVT2ItUXI4ZGFvWWlaVnJNMVd6TEhQWnkwM1FEY0llaGU2NVgxUzIyN2JPd3FXTmZoc1gwRE9NX01jTHRxYTZlZkNLTG9ZN1dTQV9Mc0JaaWVsTmpieEhtckFDUjd5QlJWTm13dmpvQ2N5NzROTndZT0…

Google News Fri, 05 Jun 2026

Veru (NASDAQ: VERU) Stock Price Surges Over 160% After Clinical Supply Deal With Novo Nordisk (NYSE: NVO) - foreignpolicyjournal.com

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxOc2dGemtoblB4Y2NIS0hUYU9pMUFfR3h1NlBsMWlHSWxJYW9XWnpaRnozMVRMTGl2eDlsR1VBY2xYYzhvNDNkYk5LYnNBSzhBajFjOEJ2bUFVS0xXaUtjMWdzZXJZdDJLVlhObi13TVZZSWViaHFackp0dWlyOWhWWFBsc1kyQ2gyN2llZj…

VERU — Frequently Asked Questions

What is the current share price of VERU?

As of 2026-08-05 17:25 PDT, VERU trades at $2.33 on NASDAQ/NYSE. Its 52-week range is $2.09 to $4.90.

What is the market capitalisation of VERU?

VERU has a market capitalisation of $34.64M on NASDAQ/NYSE.

What is the P/E ratio of VERU?

VERU trades at a trailing price-to-earnings (P/E) ratio of -1.50. Its price-to-book (P/B) ratio is 1.89.

What is the return on equity (ROE) of VERU?

VERU has a return on equity (ROE) of -123.97%.

Is VERU a good stock to buy?

This page provides a data-driven analysis of VERU, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

VERU VERU

Company Overview

Why Investors Should Care

Growth & Price Performance

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Analyst View

Latest News

Veru's obesity study expects interim data in 2027 - Stock Titan

Veru Inc. Announces August 10, 2026 Conference Call to Discuss Fiscal Third Quarter Results and Business Update - Quiver Quantitative

Veru And 2 Other Intriguing Penny Stocks To Watch - Yahoo Finance

VERU Forecast — Price Target — Prediction for 2027 - TradingView

Veru stock holds at Outperform as Oppenheimer cites Novo deal - Investing.com

Veru (NASDAQ: VERU) Stock Price Surges Over 160% After Clinical Supply Deal With Novo Nordisk (NYSE: NVO) - foreignpolicyjournal.com

VERU — Frequently Asked Questions

What is the current share price of VERU?

What is the market capitalisation of VERU?

What is the P/E ratio of VERU?

What is the return on equity (ROE) of VERU?

Is VERU a good stock to buy?

Explore More